Risk of adverse perinatal outcomes among women with clinical and subclinical histopathological chorioamnionitis

IntroductionHistologic chorioamnionitis (HCA) is a placental inflammatory condition associated with adverse perinatal outcomes (APOs). This historical cohort study explores the risk of APOs in pregnant women with HCA and compares the impact of clinical chorioamnionitis (CCA) with subclinical chorioa...

Full description

Bibliographic Details
Main Authors: Andrea Olguín-Ortega, Ricardo Figueroa-Damian, Martha Leticia Palafox-Vargas, Enrique Reyes-Muñoz
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2024.1242962/full
_version_ 1797271828838744064
author Andrea Olguín-Ortega
Ricardo Figueroa-Damian
Martha Leticia Palafox-Vargas
Enrique Reyes-Muñoz
author_facet Andrea Olguín-Ortega
Ricardo Figueroa-Damian
Martha Leticia Palafox-Vargas
Enrique Reyes-Muñoz
author_sort Andrea Olguín-Ortega
collection DOAJ
description IntroductionHistologic chorioamnionitis (HCA) is a placental inflammatory condition associated with adverse perinatal outcomes (APOs). This historical cohort study explores the risk of APOs in pregnant women with HCA and compares the impact of clinical chorioamnionitis (CCA) with subclinical chorioamnionitis (SCCA).MethodologyPlacentas were evaluated by a perinatal pathologist tand all women with HCA were included. Two groups were integrated: (1) women with clinical chorioamnionitis (CCA) and (2) women with subclinical chorioamnionitis (SCCA). Additionally, we conducted a secondary analysis to compare the prevalence of APOs among stage 1, 2 and 3 of HCA and the risk of APOs between grades 1 and 2 of HCA. The APOs analyzed were preterm birth, stillbirth, neonatal weight < 1,500 g, neonatal sepsis. Relative risk with 95% confidence interval was calculated.ResultsThe study included 41 cases of CCA and 270 cases of SCCA. The mean gestational age at diagnosis and birth was 30.2 ± 5.4 weeks and 32.5 ± 5.1 weeks, for group 1 and 2, respectively. The study also found that women with HCA stage 3 and grade 2 had a higher prevalence and risk of adverse perinatal outcomes.DiscussionThe findings of this study suggest the importance of placental histological study to excluded SCCA, which represents a significant risk to both maternal and neonatal health, contributing to high morbidity and mortality.
first_indexed 2024-03-07T14:14:51Z
format Article
id doaj.art-aae4ddbfac4b487e8461cc5dbbd3268a
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-03-07T14:14:51Z
publishDate 2024-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-aae4ddbfac4b487e8461cc5dbbd3268a2024-03-06T13:19:55ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2024-03-011110.3389/fmed.2024.12429621242962Risk of adverse perinatal outcomes among women with clinical and subclinical histopathological chorioamnionitisAndrea Olguín-Ortega0Ricardo Figueroa-Damian1Martha Leticia Palafox-Vargas2Enrique Reyes-Muñoz3Department of Gynecology, National Institute of Perinatology, Mexico City, MexicoDepartment of Infectology, National Institute of Perinatology, Mexico City, MexicoDepartment of Pathology, National Institute of Perinatology, Mexico City, MexicoCoordination of Gynecological and Perinatal Endocrinology, National Institute of Perinatology, Mexico City, MexicoIntroductionHistologic chorioamnionitis (HCA) is a placental inflammatory condition associated with adverse perinatal outcomes (APOs). This historical cohort study explores the risk of APOs in pregnant women with HCA and compares the impact of clinical chorioamnionitis (CCA) with subclinical chorioamnionitis (SCCA).MethodologyPlacentas were evaluated by a perinatal pathologist tand all women with HCA were included. Two groups were integrated: (1) women with clinical chorioamnionitis (CCA) and (2) women with subclinical chorioamnionitis (SCCA). Additionally, we conducted a secondary analysis to compare the prevalence of APOs among stage 1, 2 and 3 of HCA and the risk of APOs between grades 1 and 2 of HCA. The APOs analyzed were preterm birth, stillbirth, neonatal weight < 1,500 g, neonatal sepsis. Relative risk with 95% confidence interval was calculated.ResultsThe study included 41 cases of CCA and 270 cases of SCCA. The mean gestational age at diagnosis and birth was 30.2 ± 5.4 weeks and 32.5 ± 5.1 weeks, for group 1 and 2, respectively. The study also found that women with HCA stage 3 and grade 2 had a higher prevalence and risk of adverse perinatal outcomes.DiscussionThe findings of this study suggest the importance of placental histological study to excluded SCCA, which represents a significant risk to both maternal and neonatal health, contributing to high morbidity and mortality.https://www.frontiersin.org/articles/10.3389/fmed.2024.1242962/fullchorioamnionitispregnancy outcomeplacentapremature birthstillbirth
spellingShingle Andrea Olguín-Ortega
Ricardo Figueroa-Damian
Martha Leticia Palafox-Vargas
Enrique Reyes-Muñoz
Risk of adverse perinatal outcomes among women with clinical and subclinical histopathological chorioamnionitis
Frontiers in Medicine
chorioamnionitis
pregnancy outcome
placenta
premature birth
stillbirth
title Risk of adverse perinatal outcomes among women with clinical and subclinical histopathological chorioamnionitis
title_full Risk of adverse perinatal outcomes among women with clinical and subclinical histopathological chorioamnionitis
title_fullStr Risk of adverse perinatal outcomes among women with clinical and subclinical histopathological chorioamnionitis
title_full_unstemmed Risk of adverse perinatal outcomes among women with clinical and subclinical histopathological chorioamnionitis
title_short Risk of adverse perinatal outcomes among women with clinical and subclinical histopathological chorioamnionitis
title_sort risk of adverse perinatal outcomes among women with clinical and subclinical histopathological chorioamnionitis
topic chorioamnionitis
pregnancy outcome
placenta
premature birth
stillbirth
url https://www.frontiersin.org/articles/10.3389/fmed.2024.1242962/full
work_keys_str_mv AT andreaolguinortega riskofadverseperinataloutcomesamongwomenwithclinicalandsubclinicalhistopathologicalchorioamnionitis
AT ricardofigueroadamian riskofadverseperinataloutcomesamongwomenwithclinicalandsubclinicalhistopathologicalchorioamnionitis
AT marthaleticiapalafoxvargas riskofadverseperinataloutcomesamongwomenwithclinicalandsubclinicalhistopathologicalchorioamnionitis
AT enriquereyesmunoz riskofadverseperinataloutcomesamongwomenwithclinicalandsubclinicalhistopathologicalchorioamnionitis